We Can Medicines Co., Ltd. (TPEX:6929)

Taiwan · Delayed Price · Currency is TWD

23.35

+0.95 (4.24%)

Aug 20, 2026, 11:13 AM CST

We Can Medicines Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,207	3,222	3,269	3,123	3,303	2,794
Revenue Growth	-1.09%	-1.45%	4.69%	-5.45%	18.20%	4.77%
Gross Profit	1,053	1,068	1,104	1,023	1,112	916.55
Operating Income	-75.97	-68.02	-50.01	23.94	117.2	30.33
Net Income	-78.03	-73.21	-47.18	14.8	100.05	38.79
Earnings Per Share	-1.74	-1.63	-1.09	0.35	2.40	0.97
EPS Growth	-	-	-	-85.42%	147.46%	-27.08%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	223.72	285.75	305.67	160.53	216.26	203.36
Total Debt	1,111	1,197	1,241	1,317	1,057	890.85
Net Cash (Debt)	-886.81	-911.59	-935.62	-1,156	-841	-687.49
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-19.78	-20.26	-21.53	-27.36	-20.16	-17.19

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	320.28	240.02	260.68	139.84	346.67	457.16
Capital Expenditures	-37.33	-35.53	-63.95	-92.55	-122.54	-339.58
Free Cash Flow	282.95	204.5	196.73	47.29	224.13	117.58
Free Cash Flow Growth	7.19%	3.95%	316.03%	-78.90%	90.63%	458.55%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	32.82%	33.15%	33.77%	32.77%	33.66%	32.80%
Operating Margin	-2.37%	-2.11%	-1.53%	0.77%	3.55%	1.08%
Pretax Margin	-2.43%	-2.27%	-1.48%	0.69%	3.67%	1.39%
Profit Margin	-2.43%	-2.27%	-1.44%	0.47%	3.03%	1.39%
FCF Margin	8.82%	6.35%	6.02%	1.51%	6.79%	4.21%

Dividends

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Dividend Per Share	0.270
Dividend Per Share Growth	-
Dividend Yield	0.25%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	291.83	37.94	-
P/FCF Ratio	3.72	7.57	8.81	91.36	16.94	-
PS Ratio	0.33	0.48	0.53	1.38	1.15	-